Caleb P Nelson1, Jonathan C Routh2, Tanya Logvinenko3, Ilina Rosoklija4, Paul J Kokorowski5, Lisa A Prosser6, Mark A Schuster7. 1. Department of Urology, Boston Children's Hospital and Harvard Medical School, Boston, MA, USA; Division of General Pediatrics, Boston Children's Hospital and Harvard Medical School, Boston, MA, USA. Electronic address: caleb.nelson@childrens.harvard.edu. 2. Division of Urology, Duke University Medical Center, Durham, NC, USA. 3. Department of Urology, Boston Children's Hospital and Harvard Medical School, Boston, MA, USA; Clinical Research Center, Boston Children's Hospital, Boston, MA, USA. 4. Department of Urology, Boston Children's Hospital and Harvard Medical School, Boston, MA, USA. 5. Division of Urology, Children's Hospital of Los Angeles, University of Southern California, Los Angeles, CA, USA. 6. CHEAR Unit, General Pediatrics, University of Michigan Health System, Ann Arbor, MI, USA. 7. Division of General Pediatrics, Boston Children's Hospital and Harvard Medical School, Boston, MA, USA.
Abstract
BACKGROUND: Management of vesicoureteral reflux (VUR) continues to be controversial. In conditions of uncertainty, decision analytic techniques such as cost-utility analysis (CUA) can help to structure the decision-making process. However, CUA analyses require a "utility," a value between 0 (death) and 1 (perfect health) corresponding to the quality of life associated with a health state. Ideally, utility values are elicited directly from representative community samples, but utilities have not been rigorously measured for pediatric urology conditions. OBJECTIVES: To elicit utility scores for VUR and open anti-reflux surgery (ARS) from a representative, well-characterized community sample of adults who have been parents. METHODS: Cross-sectional survey of nationally representative adults who had ever been parents. Each respondent saw one of four descriptions of VUR, with or without continuous antibiotic prophylaxis (CAP) and occurrence of febrile urinary tract infection (UTI). A 6-week postoperative health state following ARS was also assessed. We used the time trade-off (TTO) method to elicit utility scores. Factors associated with utility score were assessed with a multivariate linear regression model. RESULTS: The survey was completed by 1200 individuals. Data were weighted to adjust for demographic differences between responders and non-responders. Mean age was 52 ± 15 years, 44% were male, and 68% were White. In terms of education, 29% had a college degree or higher. The mean utility score for VUR overall was 0.82 ± 0.28. VUR utility scores did not differ significantly based on inclusion of CAP or UTI in the health state description (p = 0.21). The 6-week postoperative period garnered a utility of 0.71 ± 0.43. DISCUSSION: Our results showed that VUR has a mean utility score of 0.82, which indicates that the community perceives this condition to be a substantial burden. For comparison, conditions with similar utility scores include compensated hepatitis B-related cirrhosis (0.80) and glaucoma (0.82); conditions with higher utilities include neonatal jaundice (0.99) and transient neonatal neurological symptoms (0.95); and conditions with lower utility scores include severe depression (0.43) and major stroke (0.30). Our results suggest that parents consider the burden associated with VUR to be significant, and that the impact of the condition on families and children is substantial. CONCLUSIONS: VUR is perceived as having a substantial impact on health-related quality of life, with a utility value of 0.82. However, use of CAP and occurrence of UTI do not seem to affect significantly the community perspective on HRQOL associated with living with VUR.
BACKGROUND: Management of vesicoureteral reflux (VUR) continues to be controversial. In conditions of uncertainty, decision analytic techniques such as cost-utility analysis (CUA) can help to structure the decision-making process. However, CUA analyses require a "utility," a value between 0 (death) and 1 (perfect health) corresponding to the quality of life associated with a health state. Ideally, utility values are elicited directly from representative community samples, but utilities have not been rigorously measured for pediatric urology conditions. OBJECTIVES: To elicit utility scores for VUR and open anti-reflux surgery (ARS) from a representative, well-characterized community sample of adults who have been parents. METHODS: Cross-sectional survey of nationally representative adults who had ever been parents. Each respondent saw one of four descriptions of VUR, with or without continuous antibiotic prophylaxis (CAP) and occurrence of febrile urinary tract infection (UTI). A 6-week postoperative health state following ARS was also assessed. We used the time trade-off (TTO) method to elicit utility scores. Factors associated with utility score were assessed with a multivariate linear regression model. RESULTS: The survey was completed by 1200 individuals. Data were weighted to adjust for demographic differences between responders and non-responders. Mean age was 52 ± 15 years, 44% were male, and 68% were White. In terms of education, 29% had a college degree or higher. The mean utility score for VUR overall was 0.82 ± 0.28. VUR utility scores did not differ significantly based on inclusion of CAP or UTI in the health state description (p = 0.21). The 6-week postoperative period garnered a utility of 0.71 ± 0.43. DISCUSSION: Our results showed that VUR has a mean utility score of 0.82, which indicates that the community perceives this condition to be a substantial burden. For comparison, conditions with similar utility scores include compensated hepatitis B-related cirrhosis (0.80) and glaucoma (0.82); conditions with higher utilities include neonatal jaundice (0.99) and transient neonatal neurological symptoms (0.95); and conditions with lower utility scores include severe depression (0.43) and major stroke (0.30). Our results suggest that parents consider the burden associated with VUR to be significant, and that the impact of the condition on families and children is substantial. CONCLUSIONS:VUR is perceived as having a substantial impact on health-related quality of life, with a utility value of 0.82. However, use of CAP and occurrence of UTI do not seem to affect significantly the community perspective on HRQOL associated with living with VUR.
Authors: Sylvie M C van Osch; Peter P Wakker; Wilbert B van den Hout; Anne M Stiggelbout Journal: Med Decis Making Date: 2004 Sep-Oct Impact factor: 2.583
Authors: Jessica C Lloyd; Talitha Yen; Ricardo Pietrobon; John S Wiener; Sherry S Ross; Paul J Kokorowski; Caleb P Nelson; Jonathan C Routh Journal: J Pediatr Urol Date: 2014-04-04 Impact factor: 1.830
Authors: Louis S Matza; Andrine R Swensen; Emuella M Flood; Kristina Secnik; Nancy Kline Leidy Journal: Value Health Date: 2004 Jan-Feb Impact factor: 5.725
Authors: Adrian R Levy; Kris V Kowdley; Uchenna Iloeje; Eskinder Tafesse; Jayanti Mukherjee; Robert Gish; Natalie Bzowej; Andrew H Briggs Journal: Value Health Date: 2007-12-17 Impact factor: 5.725
Authors: Ayal Schaffer; Anthony J Levitt; Susan K Hershkop; Paul Oh; Cathy MacDonald; Krista Lanctot Journal: Psychiatry Res Date: 2002-06-01 Impact factor: 3.222
Authors: Louis S Matza; Kristina S Boye; David H Feeny; Joseph A Johnston; Lee Bowman; Jessica B Jordan Journal: Health Qual Life Outcomes Date: 2014-04-09 Impact factor: 3.186
Authors: Marc Evans; Kamlesh Khunti; Muhammad Mamdani; Claus B Galbo-Jørgensen; Jens Gundgaard; Mette Bøgelund; Stewart Harris Journal: Health Qual Life Outcomes Date: 2013-06-03 Impact factor: 3.186
Authors: Rohit Tejwani; Hsin-Hsiao S Wang; Jessica C Lloyd; Paul J Kokorowski; Caleb P Nelson; Jonathan C Routh Journal: J Urol Date: 2016-10-13 Impact factor: 7.450
Authors: Zachary R Dionise; Juan Marcos Gonzalez; Michael L Garcia-Roig; Andrew J Kirsch; Charles D Scales; John S Wiener; J Todd Purves; Jonathan C Routh Journal: Urology Date: 2019-03-14 Impact factor: 2.649